[在深市首个进口的内脏莱什曼病例]
1Nanshan District Center for Disease Control and Prevention, Shenzhen, Guangdong 518054, China.
概括
一名被诊断患有内脏莱什曼病的患者,这是一种罕见的进口疾病,已成功治疗. 甲基因组测序确定了寄生虫,证实了诊断,并使有效的治疗成为可能.
科学领域:
- 医学寄生虫学 医学寄生虫学
- 传染性疾病 传染性疾病
- 基因组学就是基因组学.
背景情况:
- 内脏莱什曼病 (kala-azar) 是热带和亚热带地区特有的一种严重的寄生病.
- 早期诊断和治疗对于患者的生存和预防疾病传播至关重要.
- 下一代元基因组测序 (mNGS) 提供了一个强大的工具,用于识别未被诊断的发烧性疾病中的病原体.
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


